Effects of antidepressants on the production of cytokines

International Journal of Neuropsychopharmacology

Volumn 5, Issue 4, 2002, Pages 401-412

  Kenis, Gunter ^a   Maes, Michael ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Antidepressant; Cytokine; Immune system; Interleukin; Major depression

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOKINE; ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 10; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL CULTURE; CYTOKINE PRODUCTION; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOTHERAPY; INFLAMMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN CHEMISTRY; CYTOKINES; DEPRESSIVE DISORDER; HUMANS;

EID: 0036901920     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145702003164     Document Type: Review

References (78)

1. Abbas AK, Murphy KM, Sher A (1996). Functional diversity of helper T lymphocytes. Nature 383, 787-793.
2. Alvarez JC, Gluck N, Fallet A, Gregoire A, Chevalier JF, Advenier C, Spreux-Varoquaux O (1999). Plasma serotonin level after 1 day of fluoxetine treatment: A biological predictor for antidepressant response? Psychopharmacology (Berlin) 143, 97-101.
3. Anisman H, Ravindran AV, Griffiths J, Merali Z (1999). Interleukin-1 beta production in dysthymia before and after pharmacotherapy. Biological Psychiatry 46, 1649-1655.
4. Arzt E, Costas M, Finkielman S, Nahmod VE (1991). Serotonin inhibition of tumor necrosis factor-alpha synthesis by human monocytes. Life Science 48, 2557-2562.
5. Arzt ES, Fernandez-Castelo S, Finocchiaro LM, Criscuolo ME, Diaz A, Finkielman S, Nahmod VE (1988). Immunomodulation by indoleamines: Serotonin and melatonin action on DNA and interferon-gamma synthesis by human peripheral blood mononuclear cells. Journal of Clinical Immunology 8, 513-520.
6. Aune TM, Golden HW, McGrath KM (1994). Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. Journal of Immunology 153, 489-498.
7. Aune TM, McGrath KM, Sarr T, Bombara MP, Kelley KA (1993). Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine. Journal of Immunology 151, 1175-1183.
8. Benbernou N, Esnault S, Shin HC, Fekkar H, Guenounou M (1997). Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology 91, 361-368.
9. Brideau C, Van Staden C, Styhler A, Rodger IW, Chan CC (1999). The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor-α and leukotriene B4 in a novel human whole blood assay. British Journal of Pharmacology 126, 979-988.
10. Castanon N, Bluthe RM, Dantzer R (2001). Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat. Psychopharmacology (Berlin) 154, 50-60.
11. Connor TJ, Harkin A, Kelly JP, Leonard BE (2000). Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: Effect of chronic desipramine treatment. Neuroimmunomodulation 7, 27-35.
12. Connor TJ, Leonard BE (1998). Depression, stress and immunological activation: The role of cytokines in depressive disorders. Life Science 62, 583-606.
13. De Groote D, Gevaert Y, Lopez M, Gathy R, Fauchet F, Dehart I, Jadoul M, Radoux D, Franchimont P (1993). Novel method for the measurement of cytokine production by a one-stage procedure. Journal of Immunological Methods 163, 259-267.
14. De Groote D, Zangerle PF, Gevaert Y, Fassotte MF, Beguin Y, Noizat-Pirenne F, Pirenne J, Gathy R, Lopez M, Dehart I, Igot D, Baudrihaye M, Delacroix D, Franchimont P (1992). Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 4, 239-248.
15. Edgar VA, Sterin-Borda L, Cremaschi GA, Genaro AM (1999). Role of protein kinase C and cAMP in fluoxetine effects on human T-cell proliferation. European Journal of Pharmacology 372, 65-73.
16. Eigler A, Siegmund B, Emmerich U, Baumann KH, Hartmann G, Endres S (1998). Anti-inflammatory activities of cAMP-elevating agents: Enhancement of IL-10 synthesis and concurrent suppression of TNF procuction. Journal of Leucocyte Biology 63, 101-107.
17. Fekkes D, Timmerman L, Pepplinkhuizen L (1997). Effects of clomipramine on plasma amino acids and serotonergic parameters in panic disorder and depression. European Neuropsychopharmacology 7, 235-239.
18. Ferjan I, Erjavec F (1996). Changes in histamine and serotonin secretion from rat peritoneal mast cells caused by antidepressants. Inflammation Research 45, 141-144.
19. Finocchiaro LM, Arzt ES, Fernandez-Castelo S, Criscuolo M, Finkielman S, Nahmod VE (1988). Serotonin and melatonin synthesis in peripheral blood mononuclear cells: Stimulation by interferon-gamma as part of an immunomodulatory pathway. Journal of Interferon Research 8, 705-716.
20. Frommberger UH, Bauer J, Haselbauer P, Fraulin A, Riemann D, Berger M (1997). Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: Comparison between the acute state and after remission. European Archives of Psychiatry and Clinical Neurosciences 247, 228-233.
21. Hellstrand K, Czerkinsky C, Ricksten A, Jansson B, Asea A, Kylefjord H, Hermodsson S (1993). Role of serotonin in the regulation of interferon-gamma production by human natural killer cells. Journal of Interferon Research 13, 33-38.
22. Hinze-Selch D, Schuld A, Kraus T, Kuhn M, Uhr M, Haack M, Pollmacher T (2000). Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine. Neuropsychopharmacology 23, 13-19.
23. Ignatowski TA, Noble BK, Wright JR, Gorfien JL, Heffner RR, Spengler RN (1997). Neuronal-associated tumor necrosis factor (TNF alpha): Its role in noradrenergic functioning and modification of its expression following antidepressant drug administration. Journal Neuroimmunology 79, 84-90.
24. Ignatowski TA, Spengler RN (1994). Tumor necrosis factor-alpha: Presynaptic sensitivity is modified after antidepressant drug administration. Brain Research 665, 293-299.
25. Karage F, Widmer J, Bovier P, Gaillard JM (1994). Platelet serotonin and plasma tryptophan in depressed patients: Effect of drug treatment and clinical outcome. Neuropsychopharmacology 10, 207-214.
26. Katsikis PD, Cohen S, Londei M, Feldmann M (1995). Are CD4+ TH1 cells pro-inflammatory or anti-inflammatory? The ratio of IL-10 to IFN-gamma or IL-2 determines their function. International Immunology 7, 1287-1294.
27. Kelly JP, Wrynn AS, Leonard BE (1997). The olfactory bulbectomized rat as a model of depression: An update. Pharmacology and Therapeutics 74, 299-316.
28. Kleinerman ES, Knowles RD, Blick MB, Zwelling LA (1989). Lithium chloride stimulates human monocytes to secrete tumor necrosis factor/cachectin. Journal of Leukocyte Biology 46, 484-492.
29. Kronfol Z, Remick DG (2000). Cytokines and the brain: Implications for clinical psychiatry. American Journal of Psychiatry 157, 683-694.
30. Kubera M, Basta-Kaim A, Papp M (1995). The effect of chronic treatment with imipramine on the immunoreactivity of animals subjected to a chronic mild stress model of depression. Immunopharmacology 30, 225-230.
31. Kubera M, Holan V, Basta-Kaim A, Roman A, Borycz J, Shani J (1998). Effect of desipramine on immunological parameters in mice, and their reversal by stress. International Journal of Immunopharmacology 20, 429-438.
32. Kubera M, Holan V, Mathison R, Maes M (2000a). The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice. Psychoneuroendocrinology 25, 785-797.
33. Kubera M, Kenis G, Bosmans E, Scharpe S, Maes M (2000b). Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10. Neuropsychopharmacology 23, 89-98.
34. Kubera M, Lin A-H, Kenis G, Bosmans E, Van Bockstaele D, Maes M (2001a). Anti-inflammatory effects of antidepressants through suppression of the Interferon-γ/Interleukin-10 production ratio. Journal of Clinical Psychopharmacology 21, 199-206.
35. Kubera M, Maes M, Holan V, Basta-Kaim A, Roman A, Shani J (2001b). Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression. Journal of Affective Disorders 63, 171-178.
36. Kubera M, Symbirtsev A, Basta-Kaim A, Borycz J, Roman A, Papp M, Claesson M (1996). Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression. Polish Journal of Pharmacology 48, 503-506.
37. Kubera M, Simbirtsev A, Mathison R, Maes M (2000c). Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL/6 mice. Psychiatry Research 96, 255-266.
38. Kucharz EJ, Sierakowski SJ, Goodwin JS (1993). Lithium in vitro enhances interleukin-2 production by T cells from patients with systemic lupus erythematosus. Immunopharmacology and Immunotoxicology 15, 515-523.
39. Landmann R, Schaub B, Link S, Wacker HR (1997). Unaltered monocyte function in patients with major depression before and after three months of antidepressive therapy. Biological Psychiatry 41, 675-681.
40. Lanquillon S, Krieg JC, Bening-Abu-Sach U, Vedder H (2000). Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22, 370-379.
41. Licinio J, Wong M-L (1999). The role of inflammatory mediators in the biology of major depression: Central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotecion. Molecular Psychiatry 4, 317-327.
42. Lin A-H, Song C, Kenis G, Bosmans E, De Jongh R, Scharpe S, Maes M (2000). The in vitro immunosuppressive effects if moclobemide in healthy volunteers. Journal of Affective Disorders 58, 69-74.
43. Maes M (1995). The Interleukin hypothesis of major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 19, 11-38.
44. Maes M (1999). Major depression and activation of the inflammatory response system. In: Dantzer R, Wollman EE, Yirmiya R (Eds.), Cytokines, Stress and Depression (pp. 25-46). New York: Kluwer Academic/Plenum Publishers.
45. Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H (1997). Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9, 853-858.
46. Maes M, Meltzer HY, Scharpe S, Cooreman W, Uyttenbroeck W, Suy E, Vandervorst C, Calabrese J, Raus J, Cosyns P (1993). Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: Psychopathological correlates of hyperhaptoglobinemia during major depression. Psychiatry Research 47, 229-241.
47. Maes M, Meltzer HY, Eugene B, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R (1995). Increased concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. Journal of Affective Disorders 34, 301-309.
48. Maes M, Song C, Lin A-H, Bonaccorso S, Kenis G, De Jongh R, Bosmans E, Scharpe S (1999a). Negative immunoregulatory effects of antidepressants: Inhibition of interferon-γ and stimulation of interleukin-10 secretion. Neuropsychopharmacology 20, 370-379.
49. Maes M, Song C, Lin A-H, Pioli R, Kenis G, Kubera M, Bosmans E (1999b). In vitro immunoregulatory effects of lithium in healthy volunteers. Psychopharmacology (Berlin) 143, 401-407.
50. Merendino RA, Arena A, Gangemi S, Ruello A, Losi E, Bene A, D'Ambrosio FP (2000). In vitro interleukin-8 production by monocytes treated with lithium chloride from breast cancer patients. Tumori 86, 149-152.
51. Muller N, Riedel M, Gruber R, Ackenheil M, Schwarz MJ (2000). The immune system and schizophrenia. An integrative view. Annals of the New York Academy of Sciences 917, 456-467.
52. Nickola TJ, Ignatowski TA, Reynolds JL, Spengler RN (2001). Antidepressant drug-induced alterations in neuronlocalized tumor necrosis factor-alpha mRNA and alpha(2)-adrenergic receptor sensitivity. Journal of Pharmacology and Experimental Therapeutics 297, 680-687.
53. Peters M, Muller AM, Rose-John S (1998). Interleukin-6 and soluble interleukin-6 receptor: Direct stimulation of gp130 and hematopoiesis. Blood 92, 3495-3504.
54. Platzer C, Meisel C, Vogt K, Platzer M, Volk HD (1995). Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. International Immunology 7, 517-523.
55. Platzer C, Fritsch E, Elsner T, Lehmann MH, Volk HD, Prosch S (1999). Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells. European Journal of Immunology 29, 3098-3104.
56. Rapaport MH, Guylai L, Whybrow P (1999). Immune parameters in rapid cycling bipolar patients before and after lithium treatment. Journal of Psychiatry Research 33, 335-340.
57. Rapaport MH, Manji HK (2001). The effects of lithium on ex vivo cytokine production. Biological Psychiatry 50, 217-224.
58. Rothermundt M, Arolt V, Fenker J, Gutbrodt H, Peters M, Kirchner H (2001a). Different immune patterns in melancholic and non-melancholic major depression. European Archives of Psychiatry and Clinical Neurosciences 251, 90-97.
59. Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, Kirchner H (2001b). Inflammatory markers in major depression and melancholia. Journal of Affective Disorders 63, 93-102.
60. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H (1995). Cytokine production and serum proteins in depression. Scandinavian Journal of Immunology 41, 534-538.
61. + natural killer cells and related cytokines in major depression. Clinical Immunology and Immunopathology 78, 83-85.
62. Shen Y, Connor TJ, Nolan Y, Kelly JP, Leonard BE (1999). Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. Life Science 65, 1773-1786.
63. Sluzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K (1996). Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Annals of the New York Academy of Sciences 762, 474-476.
64. Sluzewska A, Sobieska M, Rybakowski JK (1997). Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression. Neuropsychobiology 35, 123-127.
65. Stefulj J, Jernej B, Cicin-Sain L, Rinner I, Schauenstein K (2000). mRNA expression of serotonin receptors in cells of the immune tissues of the rat. Brain, Behavior and Immunity 14, 219-224.
66. Suzuki E, Shintani F, Kanba S, Asai M, Nakaki T (1996). Induction of interleukin-1 beta and interleukin-1 receptor antagonist mRNA by chronic treatment with various psychotropics in widespread area of rat brain. Neuroscience Letters 215, 201-204.
67. Vitkovic L, Bockaert J, Jacque C (2000). 'Inflammatory' cytokines: Neuromodulators in normal brain? Journal of Neurochemistry 74, 457-471.
68. Weizman R, Laor N, Podliszewski E, Notti I, Djaldetti M, Bessler H (1994). Cytokine production in major depressed patients before and after clomipramine treatment. Biological Psychiatry 35, 42-47.
69. Wilson R, Fraser WD, McKillop JH, Smith J, O'Reilly DS, Thomson JA (1989). The 'in vitro' effects of lithium on the immune system. Autoimmunity 4, 109-114.
70. Wu YY, Yang XH (1991). Enhancement of interleukin 2 production in human and Gibbon T cells after in vitro treatment with lithium. Proceedings of the Society of Experimental and Biological Medicine 198, 620-624.
71. Xia Z, DePierre JW, Nassberger L (1996). Tricyclic antidepressants inhibit IL-6, IL-1β and TNF-α release in human blood monocytes and IL-2 and interferon-γ in T cells. Immunopharmacology 34, 27-37.
72. Yaqoob P, Newsholme EA, Calder PC (1999). Comparison of cytokine production in cultures of whole human blood and purified mononuclear cells. Cytokine 11, 600-605.
73. Yirmiya R (1996). Endotoxin produces a depressive-like episode in rats. Brain Research 711, 163-174.
74. Yirmiya R, Pollak Y, Barak O, Avitsur R, Ovadia H, Bette M, Weihe E, Weidenfeld J (2001). Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 24, 531-544.
75. Young MR, Kut JL, Coogan MP, Wright MA, Young ME, Matthews J (1993). Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin. Immunology 80, 395-400.
76. Young MR, Matthews JP (1995). Serotonin regulation of T-cell subpopulations and of macrophage accessory function. Immunology 84, 148-152.
77. Zangerle PF, De Groote D, Lopez M, Meuleman RJ, Vrindts Y, Fauchet F, Dehart I, Jadoul M, Radoux D, Franchimont P (1992). Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 4, 568-575.
78. Zidek Z (1999). Adenosine-cyclic AMP pathways and cytokine expression. European Cytokine Network 10, 319-328.